Pursuits
Lundbeck’s Anti-Alcoholism Pill Wins Backing of EU Regulator
This article is for subscribers only.
H. Lundbeck A/S’s Selincro, the first treatment to help people cut back on drinking without abstaining, won the backing of the European Union’s drug regulator.
Selincro is recommended for men who drink more than 60 grams of alcohol a day and for women who consume more than 40 grams daily, the European Medicines Agency said in a statement today. Sixty grams would be equal to the alcohol content of about one and a half bottles of wine, Lundbeck said.